french germain french babcp

RESEARCH

Summary of Key Research
 

Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J.,... Zajecka, J. (2000).

A comparison of nefazodone, the Cognitive Behavioral Analysis System of Psychotherapy , and their combination for the treatment of chronic depression. The New England Journal of Medicine, 342, 1462-1471. doi:10.1056/NEJM200005183422001

Type of Study: Randomized controlled trial

Number of Participants: 681 Population:

  • Age - Mean=43 years
  • Race/Ethnicity - 90.5% White
  • Gender - 65.3% Female
  • Status - Participants were outpatients recruited from treatment centers.

Location / Institution: Not Specified

Summary: (To include comparison groups, outcomes, measures, notable limitations) Eligible participants were randomly assigned to receive 12 weeks of Cognitive Behavioral Analysis System of Psychotherapy (CBASP), nefazodone, or a combination of nefazodone and CBASP. Recruited patients were required to meet study criteria on the Hamilton Rating Scale for Depression (HRSD) and to fulfill criteria for major depressive disorder from the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Outcomes were assessed using the HRSD. All three groups showed significant pretest to posttest improvement. However, improvement in the combined drug and CBASP group was greatest compared with the nefazodone alone group and the CBASP-only group. Limitations include lack of long-term follow-up, lack of a placebo-only control, and reduced generalizability due to restrictive participant exclusion criteria.

Length of post-intervention follow-up: None.
 

Nemeroff, C. B., Heim, C. M., Thase, M. E., Klein, D. N., Rush, A. J.,... Keller, M. B. (2003).

Differential responses to psychotherapy versus pharmacotherapy with chronic forms of major depression and childhood trauma. National Academy of Sciences, 100, 14293-14296.

Type of Study: Randomized controlled trial

Number of Participants: 681 Population:

  • Age - Mean=43 years
  • Race/Ethnicity - 90.5% Caucasian
  • Gender - Not Spectified
  • Status - Participants were outpatients recruited from treatment centers.

Location / Institution: Not Specified

Summary: (To include comparison groups, outcomes, measures, notable limitations)

Note: This study uses the same sample as Keller et al. (2000). Eligible participants were randomly assigned to receive 12 weeks of Cognitive Behavioral Analysis System of Psychotherapy (CBASP), nefazodone, or a combination of nefazodone and CBASP. Depression outcomes were assessed using the Hamilton Rating Scale for Depression (HRSD). Participants also completed the Childhood Trauma Scale (CTS) at baseline to assess the presence of childhood trauma (parental loss, physical abuse, sexual abuse, neglect or other trauma). Results showed a significantly different pattern of treatment response in participants who reported childhood trauma from those who did not. For those who reported no trauma, Nefazodone combined with CBASP was significantly superior to either CBASP or drug therapy alone. In comparison, participants with a history of trauma showed a significantly better response to CBASP than to drug therapy, and the combination of drug and CBASP was not better than CBASP alone. Limitations include limited generalizability to other populations than individuals with major depressive disorder.

Length of post-intervention follow-up: None.
 

Manber, R., Arnow, B. A., Blasey, C., Vivian, D., McCullough, J. P., Blalock, J. A.,... Keller M. B. (2003).

Patient's therapeutic skill acquisition and response to psychotherapy, alone and in combination with medication. Journal of Psychological Medicine, 33, 693-702.

Type of Study: Randomized controlled trial

Number of Participants: 431

Population:

  • Age - 18-75 years
  • Race/Ethnicity - 91.9% White
  • Gender - 66.4% Female
  • Status - Participants were outpatients recruited from treatment centers.

Location / Institution: Not Specified

Summary: (To include comparison groups, outcomes, measures, notable limitations)

Note: This study analyzes a subsample from Keller et al. (2000). Eligible participants were randomly assigned to receive 12 weeks of Cognitive Behavioral Analysis System of Psychotherapy (CBASP), nefazodone, or a combination of drug and CBASP. Depression outcomes were assessed using the Hamilton Rating Scale for Depression (HRSD). The current analysis also looked at therapists’ assessments of patients’ skill acquisition during the course of therapy using the Patient Performance Rating Form. Results showed differences in skill acquisition across treatment groups. Limitations include results may be specific to the treatments provided, CBASP and nefazodone, and may not generalize to other forms of psychotherapy or to other antidepressant medications, generalizability due to sample, population and ethnicity, and may be specific to major depressive disorder only.

Length of post-intervention follow-up: None.

Klein, D. N., Santiago, N. J., Vivian, D., Arnow, B. A., Blalock, J. A., Dunner, D. L.,... Keller, M. B. (2004).

Cognitive-Behavioral Analysis System of Psychotherapy as a maintenance treatment for chronic depression. Journal of Consulting and Clinical Psychology, 72(4), 681-688.

Type of Study: Randomized controlled trial

Number of Participants: 82 Population:

  • Age - Mean=45.1 years
  • Race/Ethnicity - 91.5% White
  • Gender - 67.1% Female and 32.9% Male
  • Status - Participants were outpatients recruited from treatment centers.

Location / Institution: Not Specified

Summary: (To include comparison groups, outcomes, measures, notable limitations)

Note: This study is a continuation of Keller et al. (2000), and uses a subsample of the original sample. Patients who had responded to their initial 12 weeks treatment in Keller et al. (2000) study were randomly assigned to receive monthly maintenance Cognitive Behavioral Analysis System of Psychotherapy (CBASP) or to assessment alone for a further year. Recruited patients were required to meet study criteria on for severe chronic depressive from the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Measures utilized were the Hamilton Depression Rating Scale (HRSD) and the Inventory of Depressive Symptoms, Self-Report version (IDS-SR-30). Participants in the CBASP maintenance condition were less likely to experience recurrence of depression than those in the assessment-only condition. CBASP patients also showed a small reduction in symptoms over time, while those in the assessment-only condition showed a small increase. Significantly fewer patients in CBASP experienced a recurrence compared to those in the assessment-only condition. The two conditions also differed significantly on change in depressive symptoms over time. Limitations include sample size, generalizability due to gender and disorder, and reliability of both instruments utilized in study.

Length of post-intervention follow-up: None.
 

Schramm, E., Zobel, I., Dykierek, P., Kech, S., Brakemeier, E. L., Kulz, A., and Berger, M. (2011).

Cognitive Behavioral Analysis System of Psychotherapy versus Interpersonal Psychotherapy for early-onset chronic depression: A randomized pilot study. Journal of Affective Disorders, 129(1-3), 109-116.

Type of Study: Randomized controlled trial

Number of Participants: 30 Population:

  • Age - 18- 65 years
  • Race/Ethnicity - Not Specified
  • Gender - Not Specified
  • Status - Participants were patients who met Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for a current episode of chronic Major Depressive Disorder (MDD), MDD superimposed on a preexisting dysthymic disorder, recurrent MDD with incomplete remission between episodes in a patient with a current MDD and a total duration of at least 2 years, or dysthymia.

Location / Institution: Department of Psychiatry and Psychotherapy of the University Medical Center Freiburg, Germany

Summary: (To include comparison groups, outcomes, measures, notable limitations) This study examined patients with early-onset chronic depression randomly assigned to Cognitive Behavioral Analysis System of Psychotherapy (CBASP) or Interpersonal Psychotherapy (IPT). Measures utilized were Hamilton Rating Scale for Depression (HRSD), the Child Trauma Questionnaire, Structured Clinical Interview for DSM-IV and the Beck Depression Inventory (BDI). There was no significant difference in post-treatment HRSD scores between the CBASP and the IPT condition, but a significant difference was seen on the self-rated BDI scores, with subjects in the CBASP condition reporting a significantly higher reduction in self-rated depressive symptoms. Significantly higher remission rates were found in CBASP (57%) as compared to the IPT (20%) group. One year post-treatment, no significant differences were found between the two groups in the self-reported symptom level (BDI). Limitations include small sample size which may limit the statistical power of the study.

Length of post-intervention follow-up: 12 months.
 

Klein, D. N., Leon, A. C., Li, C., D'Zurilla, T. J., Black, S. R., Vivian, D.,... Kocsis, J. H. (2011).

Social problem solving and depressive symptoms over time: A randomized clinical trial of Cognitive-Behavioral Analysis System of Psychotherapy, brief supportive psychotherapy, and pharmacotherapy. Journal of Consulting and Clinical Psychology, 79(3), 342-352.

Type of Study: Randomized controlled trial

Number of Participants: 491

Population:

  • Age - 18-75 years
  • Race/Ethnicity - 85.1% White, 4.3% Black, and 6.1% Other
  • Gender - 42.8% Male
  • Status - Participants were recruited at eight sites through outreach to clinicians and advertising. All patients met criteria for major depressive disorder and had achieved less than full remission following treatment with antidepressant medication. Location / Institution: Eight sites in the US

Summary: (To include comparison groups, outcomes, measures, notable limitations) This study examined the associations between treatment, social problem solving, and depression in a randomized clinical trial testing the efficacy of psychotherapy augmentation for chronically depressed patients who failed to fully respond to an initial trial of pharmacotherapy. Subjects with chronic depression were randomly assigned to Cognitive-Behavioral Analysis System of Psychotherapy (CBASP) plus medication, Brief Supportive Psychotherapy (BSP) plus medication, or medication alone for 12 weeks. Measures included the Social Problem Solving Inventory–Revised and the Hamilton Depression scale. CBASP plus pharmacotherapy was associated with significantly greater improvement in social problem solving than BSP plus pharmacotherapy, and a trend for greater improvement in problem solving than pharmacotherapy alone. In addition, change in social problem solving predicted subsequent change in depressive symptoms over time. However, the magnitude of the associations between changes in social problem solving and subsequent depressive symptoms did not differ across treatment conditions. Limitations include a lack of post-intervention follow-up and concerns regarding generalizability; as the study was conducted at academic centers.

Length of post-intervention follow-up: None.
 

Swan, J. S., MacVicar, R., Christmas, D., Durham, R., Rauchhaus, P., McCullough Jr, J. P., and Matthews, K. (2014).

Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for chronic depression: Clinical characteristics and six month clinical outcomes in an open case series. Journal of Affective Disorders, 152, 268-276.

Type of Study: Pretest/Posttest

Number of Participants: 74

Population:

  • Age - 18-72 years
  • Race/Ethnicity - 68% Women and 32% Men
  • Gender - 100% White
  • Status - Participants were outpatient clients recruited from treatment centers.

Location / Institution: Tayside and Lothian, Scotland, UK

Summary: (To include comparison groups, outcomes, measures, notable limitations) This study evaluated the effectiveness of a trial of 20 sessions of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) over a 6-month period. A comparison group was not utilized. Measures utilized include the Mini International Neuropsychiatry Interview V.5 (MINI), the Hamilton Rating Scale for Depression 24-item version (HRSD-24), the Beck Depression Inventory-II (BDI-II), the Brief Symptom Inventory (BSI), and the Childhood Trauma Questionnaire (CTQ). Results indicate that over half of the patients made significant clinical gains. Almost a third of the parents achieved remission and almost a third of them met criteria for clinically significant improvement. Group measures of quality of life, social functioning, and interpersonal functioning also improved. Limitations include no randomization of participants, lack of a control group, a high dropout rate, lack of generalizability of findings due the sample containing no racial/ethnic diversity, and lack of follow-up.

Length of post-intervention follow-up: None.

Michalak, J., Heidenreich, T., Schultze, M., Schramm, E. (2015).

A Randomized Controlled Trial on the Efficacy of Mindfulness-Based Cognitive Therapy and a Group Version of Cognitive Behavioral Analysis System of Psychotherapy for Chronically Depressed Patients. Journal of Consulting and Clinical Psychology 83 (5) 951–963

Negt, P., Brakemeier, E-L., Michalak, J., Winter, L., Bleich, S., Kahl, K. G. (2016). 

The treatment of chronic depression with cognitive behavioral analysis system of psychotherapy: a systematic review and meta-analysis of randomized-controlled clinical trials. Brain and Behavior, 3;6(8):e00486

Bausch, P., Fangmeier, T., Schramm, E., Zobel, I., Drost, S., Schnell, K., Walter, H., Berger, M., Schoepf,  D. & Normann, C. (2017)

Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Patients with Chronic Depression: Results from a Naturalistic Long-Term Follow-Up.  Psychotherapy and Psychosomatics. 84(4), 227-240.

Jobst, A., Brakemeier, E.L., Buchheim,A., Caspar, F., Cuijpers, P., Ebmeier, K.P., Falkai, P., van der Gaag,R.J., Gaebel, W., Herpertz, S., Kurimay, T., Sabaß, L., Schnell, K., Schramm, E., Torrent, C., Wasserman, D., Wiersma, J. & Padberg, F. (2016).

European Psychiatric Association Guidance on Psychotherapy in Chronic Depression across Europe. European Psychiatry (33), 18-38.